Shenzhen Oralead Pharma Co., Ltd.
- Biotech or pharma, therapeutic R&D
Shenzhen Oralead Pharma was established in August 2022 and founded by Dr. Dou Liu, who graduated from the research group of Professor Abdul Basit, a world-renowned authority in the field of oral drug formulations and a tenured professor at University College London in the UK. Since its establishment, Oralead has been focusing on the oral delivery technology of macromolecular drugs. It has achieved phased results in the field of oral formulations for polypeptide molecules. At the same time, it has also made technological breakthroughs in areas such as mRNA and monoclonal antibodies.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}